No, not evergreening, just the regular.... The facts have been analyzed in the OECD countries, who pays the most per comparative population for drugs, and we are really in the highest.... It's not necessarily evergreening. Evergreening is the new measure that the companies are thinking about. It is a fact, whether they discuss the measures the companies use or whether it's just the number of drugs that people are being prescribed.
On September 26th, 2016. See this statement in context.